Synbio Tech Inc. (TPEX:1295)

Market Cap	3.77B
Revenue (ttm)	994.50M
Net Income (ttm)	172.45M
Shares Out	34.47M
EPS (ttm)	5.47
PE Ratio	20.02
Forward PE	17.12
Dividend	3.50 (3.10%)
Ex-Dividend Date	Mar 27, 2025

Volume	22,000
Average Volume	912,369
Open	109.00
Previous Close	109.50
Day's Range	109.00 - 112.50
52-Week Range	58.50 - 147.00
Beta	n/a
RSI	42.59
Earnings Date	Aug 8, 2025

About Splunk

Synbio Tech Inc. engages in the manufacturing of human healthcare and the research on probiotics for economic animals. It offers lactobacillus plantarum powder and derivatives of fermented lactic acid bacteria, as well as probiotics for dietary supplements, pets, economic animals, and plant preservation. It also provides single probiotic strain and multi strain probiotics, and functional strain. Its functional strain includes SynForU-MemoryUp, a solution for brain health; Lactobacillus plantarum TWK10 for exercise performance; ABKEFIR to improv...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2000
• Employees: 92
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 1295

Financial Performance

In 2024, Synbio Tech's revenue was 989.48 million, an increase of 20.18% compared to the previous year's 823.30 million. Earnings were 170.13 million, an increase of 50.19%.